Recent Articles from Benzinga
Benzinga, founded in 2010 by Jason Raznick and headquartered in Detroit, Michigan, is a dynamic financial media and technology company dedicated to empowering individual investors with timely, actionable insights. Initially launched from Raznick’s basement with a modest $10,000 investment, the company has grown into a trusted resource, attracting approximately 25 million monthly readers through its innovative blend of real-time financial news, market analysis, and trading tools.
Website: https://www.benzinga.com
Via Benzinga · July 31, 2025
Via Benzinga · July 31, 2025
Via Benzinga · July 31, 2025
Via Benzinga · July 31, 2025
Via Benzinga · July 31, 2025
Via Benzinga · July 31, 2025
Via Benzinga · July 31, 2025
Palo Alto's CyberArk acquisition sparks concerns over strategic fit, integration risk, and weakening organic demand.
Via Benzinga · July 31, 2025
Shares of telehealth company Hims & Hers Health are up Thursday afternoon. The rally comes amid significant headwinds for major pharmaceutical companies in the lucrative weight-loss drug market.
Via Benzinga · July 31, 2025
Although Sanofi delivered an earnings miss which still had encouraging results, SNY stock tanked, offering a potential contrarian discount.
Via Benzinga · July 31, 2025
UnitedHealth Group Inc. (NYSE: UNH) shares are trading lower Thursday, after Baird downgraded the stock to Underperform and slashed its price target from $312 to $198.
Via Benzinga · July 31, 2025
The Roundhill Magnificent Seven ETF surged to an all-time high Thursday morning. The ETF is being powered by blockbuster quarterly earnings from key holdings Microsoft and Meta Platforms.
Via Benzinga · July 31, 2025
Qualcomm's Q3 performance boosted by automotive and IoT growth, but cautious outlook and China risks send shares down. Analysts remain optimistic.
Via Benzinga · July 31, 2025
Alnylam stock jumps after Q2 earnings beat and higher 2025 guidance, led by Amvuttra's rapid uptake and strong growth across the TTR and Rare franchises.
Via Benzinga · July 31, 2025
Via Benzinga · July 31, 2025
Jesse Eisenberg starred in the 2010 film "The Social Network." A sequel will likely feature someone else portraying Mark Zuckerberg.
Via Benzinga · July 31, 2025
Silexion's SIL204 showed strong KRAS-targeted inhibition across pancreatic, colorectal, and lung cancer cells, supporting its advancement to clinical trials.
Via Benzinga · July 31, 2025
Lam Research (LRCX) beat earnings expectations and raised its guidance, thanks to strong demand from China. Shares fell due to concerns over this growth's sustainability.
Via Benzinga · July 31, 2025
Via Benzinga · July 31, 2025
Via Benzinga · July 31, 2025
Via Benzinga · July 31, 2025
Via Benzinga · July 31, 2025
Via Benzinga · July 31, 2025
State Street Investment Management introduces 11 Select Sector SPDR Premium Income ETFs, combining sector exposure with covered-call approach for income.
Via Benzinga · July 31, 2025
Align Technology reported a Q2 miss and issued cautious guidance as dental practices faced fewer patient starts and economic headwinds.
Via Benzinga · July 31, 2025
SEC unveils Project Crypto to modernize securities regulations for blockchain-based systems. Feedback from public will be considered.
Via Benzinga · July 31, 2025
Via Benzinga · July 31, 2025
Via Benzinga · July 31, 2025
Via Benzinga · July 31, 2025
Via Benzinga · July 31, 2025
Via Benzinga · July 31, 2025
Via Benzinga · July 31, 2025
Via Benzinga · July 31, 2025
Via Benzinga · July 31, 2025
Via Benzinga · July 31, 2025
Via Benzinga · July 31, 2025
Via Benzinga · July 31, 2025
Via Benzinga · July 31, 2025
Via Benzinga · July 31, 2025
Via Benzinga · July 31, 2025
The new season of "South Park" is kicking off with a bang, with huge viewership figures for an episode poking fun at President Trump.
Via Benzinga · July 31, 2025
Via Benzinga · July 31, 2025